EC Paediatrics

Research Article Volume 10 Issue 9 - 2021

Neonatal Morbidity and Mortality of Retro Placental Hematoma among New-Borns at the Mother-Child University Hospital Centre Jeanne Ebori Foundation

Kuissi Kamgaing E1,2*, Lembet Mikolo A1,2, Mintsa-Mi-Nkama E2, Koumba Maniaga R1,2, Busughu-Bu-Mbadinga I2, Loulouga P1, Kwete A2, Abang Ekouaghe L1,2, Koko J1 and Ategbo S1,2

1Department of Pediatrics, University of Health Sciences, BP, Libreville, Gabon
2Child Pole, Centre Hospitalo-Universitaire mère enfant Fondation Jeanne Ebori of Libreville (CHUMEFJE), BP, Libreville, Gabon

*Corresponding Author: Kuissi Kamgaing E, Department of Pediatrics, University of Health Sciences, BP, Libreville, Gabon.
Received: July 28, 2021; Published: August 27, 2021




Objective: Describe the epidemiological, clinical and prognostic aspects of newborns from mothers managed for placental retro hematoma.

Patients and Methods: We conducted a cross-sectional, descriptive and analytical study over 24 months in the neonatal medicine department of the CHUMEFJE. All neonates, born against a background of placental retro hematoma were included. The parameters studied were, frequency, clinical picture, management and complications.

Results: 137 newborns were included, a prevalence of 1.3%. The mean gestational age was 34.9 SA; the sex ratio was 1.2. The average age of mothers was 29.1 ± 6 years. In 55.7% of cases, at least 4 prenatal contacts were made. Gravid arterial hypertension was observed in 31.3% of the cases, among them, 80.5% had a severe form. SHER grade III retro placental hematoma was observed in 49.6% of cases. Caesarean section was the voice of delivery in 97.8% of cases. Fetal death in utero was observed in 47.4% of cases. Of the 72 live newborns, 59.7% were hospitalized in neonatology. The top 3 complications observed were metabolic (81.4%), respiratory (62.8%) and hematological (46.5%). Perinatal mortality was 56.2%. Factors associated with this mortality were GRADES II and III of SHER and gestational age < 37SA (p < 0.05).

Conclusion: Retro-placental hematoma remains a serious pathology associated with high neonatal mortality.

 

Keywords: PRH; Newborn; Mortality; Morbidity; Gabon

  1. Ducloy-Bouthors AS., et al. “Hémorragies du troisième trimester”. 51e Congrès national d’anesthésie et de réanimation. Médecins. Urgences vitales. Paris. Elsevier Masson SAS (2009).
  2. Biaye B., et al. “Epidemiology and Prognosis of Retroplacental Hematoma in a Maternity Ward at a Regional Hospital Center in Southern Senegal”. Open Journal of Obstetrics and Gynecology 9 (2019): 149-157.
  3. Bohec C and Collet M. “Abruptio Placentae”. Annales Francaises d’Anesthésie et de Réanimation 29 (2015): 115-119.
  4. Thiam O., et al. “Aspects épidémiologiques, pronostiques et thérapeutiques de l'HRP dans une maternité de référence en zone rurale”. The Pan African Medical Journal 17 (2014): 1-4.
  5. Granito-Martinez M. “L’hématome rétro-placentaire: état des lieux au CHU de Grenoble”. Gynécologie et Obstétrique (2016).
  6. Rakotozanany B., et al. “Place du traitement chirurgical et pronostic materno-fœtal de l’hématome rétroplacentaire à la Maternité de Befelatanana, Madagascar”. Revista Española de Anestesiología y Reanimación . Medicine and Toxicology1 (2017): 10-12.
  7. Mezane S., et al. “Hématome retro-placentaire et mort foetale in utero: à propos de 49 cas et revue de la littérature”. International Journal of Innovation and Applied Studies2 (2013): 570-578.
  8. Furukawa S., et al. “Is the perinatal outcome of placental abruption modified by clinical presentation?” Journal of Pregnancy (2011).
  9. Sananes N., et al. “Hématome rétroplacentaire”. EMC-Obstétrique3 (2012): 1-11.
  10. Mukherjee S., et al. “Retrospective study of risk factors and maternal and fetal outcome in patients with abruption placentae”. Journal of Natural Science, Biology and Medicine 5 (2014): 425-428.
  11. Nayama M., et al. “Abruption placentae management in a reference Nigerien maternity: Prospective study about 118 cases during one year”. Gynaecology Obstetrics Fertility10 (2007): 975-981.
  12. Sher G A. “Rational basis for the management of abruption placental”. Journal of Reproductive Medicine 21 (1978): 123-129.
  13. Mian DB., et al. “Hématome retroplacentaire (HRP) et mort fœtale in utéro (MFIU): à propos de 70 cas et revue de la littérature”. Rev Anesth Réanim Med Urg1 (2014): 37-42.
  14. Abdelkader F., et al. “Hématome retro placentaire aspects épidémiologiques cliniques, thérapeutiques et pronostiques au centre hospitalier national à propos de 97 cas”. International Journal of Advanced Research12 (2019): 785-789.
  15. Mounanga N., et al. “Complications maternelles et foetales de l’HTA au cours de la grossesse. À propos d’une étude rétrospective de 78 cas”. Tropical Medicine 36 (1989): 576-579.
  16. Gueneuc A., et al. “Hématome rétroplacentaire: terrain et facteurs pronostiques revisités à propos d’une série de 171 cas en Guyane française”. Journal de Gynécologie Obstétrique et Biologie de la Reproduction3 (2016): 300-306.
  17. Thieba B., et al. “Hématome rétro-placentaire: aspects épidémio-cliniques et pronostiques à propos d’une série de 177 cas”. Gynecologie Obstetrique Fertilite5 (2003): 429-433.
  18. Berkane N., et al. “Hématome rétroplacentaire”. Revue du Praticien Gynécologie Obstétrique 59 (2002): 19-22.
  19. Boisrame T., et al. “Hématome rétroplacentaire. Diagnostic, prise en charge et pronostic materno foetal. Etude rétrospective de 100 cas”. Gynécologie Obstétrique and Fertilité 42 (2014): 78-83.
  20. Thieba B., et al. “L'hématome retro placentaire dans le Service de Gynécologie-Obstétrique de CHNYO de Ouagadougou: aspects épidémio-cliniques et pronostiques”. Journal de la SAGO2 (2001): 10-14.

Kuissi Kamgaing E., et al. “Neonatal Morbidity and Mortality of Retro Placental Hematoma among New-Borns at the Mother-Child University Hospital Centre Jeanne Ebori Foundation”. EC Paediatrics 12.1 (2021): 71-79.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net